Want to see HK:6078 full AI Analyst Report?
6078 Stock Chart & Stats
HK$9.93
HK$0.07(0.70%)
At close: 4:00 PM EDT
HK$9.93
HK$0.07(0.70%)
Day’s Range― - ―
52-Week RangeHK$8.10 - HK$16.46
Previous CloseN/A
Volume725.80K
Average Volume (3M)7.15M
Market Cap
HK$5.99B
Enterprise ValueHK$9.60K
Total Cash (Recent Filing)HK$741.02M
Total Debt (Recent Filing)HK$2.45B
Price to Earnings (P/E)119.5
Beta1.44
Next Earnings
Aug 27, 2026EPS Estimate
0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding618,499,000
10 Day Avg. Volume3,556,037
30 Day Avg. Volume7,151,771
Financial Highlights & Ratios
PEG Ratio-0.58
Price to Book (P/B)1.02
Price to Sales (P/S)1.72
P/FCF Ratio14.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$13.50Price Target Upside35.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.85
Revenue Forecast (FY)HK$4.26B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthSustained multi-year top-line growth indicates expanding patient volumes or service penetration and supports scale advantages. Over 2–6 months this underpins revenue resilience, helps absorb fixed costs, and provides a base for profitable recovery if margins stabilize.
Manageable LeverageRelatively low and improving debt-to-equity gives the company financial flexibility to fund capex, acquisitions or weather cyclical pressures without heavy refinancing risk. This strengthens balance-sheet durability and supports longer-term strategic initiatives.
Improving Cash GenerationA rebound in operating and free cash flow signals improving cash conversion capacity, enabling internal funding for reinvestment or deleveraging. Over the medium term this enhances financial self-sufficiency and reduces reliance on external capital markets.
Bears Say
Sharp 2025 Profitability DropA large margin decline materially reduces return on invested capital and internal funding for growth. If driven by structural cost increases, pricing pressure, or recurring items, the deterioration could persist and constrain reinvestment, dividend capacity and long-term ROE.
Inconsistent Cash ConversionVolatile cash conversion weakens the link between reported earnings and actual liquidity. This increases uncertainty around funding for capex, working capital, or debt service, making planning and stress resilience harder despite positive headline cash flow in a single year.
Earnings And EPS VolatilitySteep year-over-year EPS decline and negative revenue growth indicate high earnings volatility. Such swings reduce predictability of free cash flow and returns, complicate long-term budgeting, and increase execution risk for strategic investments or margin recovery plans.
Hygeia Healthcare Holdings Co., Ltd. News
6078 FAQ
What was Hygeia Healthcare Holdings Co., Ltd.’s price range in the past 12 months?
Hygeia Healthcare Holdings Co., Ltd. lowest stock price was HK$8.10 and its highest was HK$16.46 in the past 12 months.
What is Hygeia Healthcare Holdings Co., Ltd.’s market cap?
Hygeia Healthcare Holdings Co., Ltd.’s market cap is HK$5.99B.
When is Hygeia Healthcare Holdings Co., Ltd.’s upcoming earnings report date?
Hygeia Healthcare Holdings Co., Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 11 days.
How were Hygeia Healthcare Holdings Co., Ltd.’s earnings last quarter?
Hygeia Healthcare Holdings Co., Ltd. released its earnings results on Mar 30, 2026. The company reported -HK$0.151 earnings per share for the quarter, missing the consensus estimate of -HK$0.14 by -HK$0.012.
Is Hygeia Healthcare Holdings Co., Ltd. overvalued?
According to Wall Street analysts Hygeia Healthcare Holdings Co., Ltd.’s price is currently Undervalued.
Does Hygeia Healthcare Holdings Co., Ltd. pay dividends?
Hygeia Healthcare Holdings Co., Ltd. pays a Notavailable dividend of HK$0.164 which represents an annual dividend yield of N/A. See more information on Hygeia Healthcare Holdings Co., Ltd. dividends here
What is Hygeia Healthcare Holdings Co., Ltd.’s EPS estimate?
Hygeia Healthcare Holdings Co., Ltd.’s EPS estimate is 0.35.
How many shares outstanding does Hygeia Healthcare Holdings Co., Ltd. have?
Hygeia Healthcare Holdings Co., Ltd. has 618,499,000 shares outstanding.
What happened to Hygeia Healthcare Holdings Co., Ltd.’s price movement after its last earnings report?
Hygeia Healthcare Holdings Co., Ltd. reported an EPS of -HK$0.151 in its last earnings report, missing expectations of -HK$0.14. Following the earnings report the stock price went down -0.348%.
Which hedge fund is a major shareholder of Hygeia Healthcare Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in HK:6078
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hygeia Healthcare Holdings Co., Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$13.50 (35.95% Upside)
HK$13.50 (35.95% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.60%
Trailing 12-Months
Company Description
Hygeia Healthcare Holdings Co., Ltd.
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
6078 Stock 12 Month Forecast
Average Price Target
HK$13.50
▲(35.95% Upside)
Technical Analysis
Aidigong Maternal & Child Health
―
Jinxin Fertility Group Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―